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Risk of suicide and repeat self-harm after hospital 
attendance for non-fatal self-harm in Sri Lanka: 
a cohort study
Duleeka Knipe, Chris Metcalfe*, Keith Hawton, Melissa Pearson, Andrew Dawson, Shaluka Jayamanne, Flemming Konradsen, Michael Eddleston, 
David Gunnell*
Summary
Background Evidence from high income countries (HICs) suggests that individuals who present to hospital after self-
harm are an important target for suicide prevention, but evidence from low and middle-income countries (LMICs) is 
lacking. We aimed to investigate the risk of repeat self-harm and suicide, and factors associated with these outcomes, 
in a large cohort of patients presenting to hospital with self-harm in rural Sri Lanka.
Methods In this cohort study, hospital presentations for self-harm at 13 hospitals in a rural area of North Central 
Province (population 224 000), Sri Lanka, were followed up with a self-harm surveillance system, established as part 
of a community randomised trial, and based on data from all hospitals, coroners, and police stations in the study area. 
We estimated the risk of repeat non-fatal and fatal self-harm and risk factors for repetition with Kaplan-Meier methods 
and Cox proportional hazard models. Sociodemographic (age, sex, and socioeconomic position) and clinical (past self-
harm and method of self-harm) characteristics investigated were drawn from a household survey in the study area 
and data recorded at the time of index hospital presentation. We included all individuals who had complete data for 
all variables in the study in our primary analysis.
Findings Between July 29, 2011, and May 12, 2016, we detected 3073 episodes of self-harm (fatal and non-fatal) in our 
surveillance system, of which 2532 (82·3%) were linked back to an individual in the baseline survey. After exclusion 
of 145 ineligible episodes, we analysed 2259 index episodes of self-harm. By use of survival models, the estimated risk 
of repeat self-harm (12 months: 3·1%, 95% CI 2·4–3·9; 24 months: 5·2%, 4·3–6·4) and suicide (12 months: 0·6%, 
0·4–1·1; 24 months: 0·8%, 0·5–1·3) in our study was considerably lower than that in HICs. A higher risk of repeat 
self-harm was observed in men than in women (fatal and non-fatal; hazard ratio 2·0, 95% CI 1·3–3·2; p=0·0021), in 
individuals aged 56 years and older compared with those aged 10–25 years (fatal; 16·1, 4·3–59·9; p=0·0027), and 
those who used methods other than poisoning in their index presentation (fatal and non-fatal; 3·9, 2·0–7·6; 
p=0·00027). We found no evidence of increased risk of repeat self-harm or suicide in those with a history of self-harm 
before the index episode.
Interpretation Although people who self-harm are an important high-risk group, focusing suicide prevention efforts 
on those who self-harm might be somewhat less important in LMICs compared with HICs given the low risk of 
repeat self-harm and subsequent suicide death. Strategies that focus on other risk factors for suicide might be more 
effective in reducing suicide deaths in LMICs in south Asia. A better understanding of the low incidence of repeat 
self-harm is also needed, as this could contribute to prevention strategies in nations with a higher incidence of 
repetition and subsequent suicide death.
Funding Wellcome Trust.
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction
Suicide is a major cause of mortality worldwide, with 
nearly 40% of deaths occurring in low-income and 
middle-income countries (LMICs) in the WHO south-
east Asian region, despite this region containing only 
26% of the global population.1 The epidemiology of 
suicide in LMICs differs from high income countries 
(HICs), with higher rates (deaths per 100 000 people per 
year) in young people (especially young women) and a 
narrower overall male to female rate ratio (1·6 in LMICs 
vs 3·5 in HICs).1
Evidence primarily from HICs suggests that previous 
non-fatal self-harm is the strongest risk factor for future 
suicide. An estimated 1·6% of those who self-harm will 
die by suicide in the subsequent year, and up to 3·9% in 
the subsequent 5 years.2 In the 1990s in the UK, 15% 
(95% CI 11–21) of people who died by suicide had 
attended an accident and emergency department for self-
harm in the year before their death.3 Therefore, people 
who present to hospital after self-harm are an important 
target for suicide prevention efforts in HICs.4,5 There is, 
however, a paucity of evidence from LMICs in south Asia 
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regarding the risk of suicide after a self-harm episode.2 
The few south Asian studies on this issue indicate that 
the risk of repeat self-harm is lower than in HICs,6–10 but 
there have been few prospective studies and most studies 
to date have been small and of low quality. A large 
prospective study10 restricted to people who had self-
poisoned in a rural region of Sri Lanka reported that the 
risk of repeat self-poisoning at 12 months was 5·7% 
(95% CI 5·0–6·4) and of suicide (all methods) at 2 years 
was 0·7% (0·4–0·9), considerably lower than the risks 
reported in HICs.
The aim of this study was to determine whether the 
aftercare of people presenting to hospital with self-harm 
should be an important priority for suicide prevention in 
LMICs. By use of data from a comprehensive suicide and 
self-harm surveillance system established as part of a 
large community cluster randomised controlled trial in 
rural Sri Lanka,11 we aimed to answer the following 
questions: what is the risk of repeat self-harm in 
individuals who present to hospital; what factors are 
associated with an increased risk of self-harm repetition; 
and are individuals who self-harm (non-fatally) at an 
increased risk of subsequent suicide?
Methods
Study design and participants
This cohort study was based in Sri Lanka, which has a 
population of 21 million. The randomised trial that formed 
the basis of this cohort study was done in the North Central 
Province of the country and recruited 95% of households 
(n=53 382; comprising 223 861 individuals) in the study 
area.11 The trial investigated the effectiveness of the 
provision of lockable pesticide storage containers in 
reducing the incidence of pesticide self-poisoning.11 
Almost 80% of households in the study area engaged in 
some sort of farming activity.11 For this analysis, we 
included data that were collected in the self-harm 
surveillance system for the trial and could be linked to 
individuals included in the trial baseline survey. The 
baseline survey was done between Dec 31, 2010, and 
Feb 2, 2013, and included detailed face-to-face interviews 
in the local language in each house by trained interviewers, 
with one key informant per household and regular data 
quality checks.11,12
We used the self-harm surveillance system to identify 
all episodes of non-fatal and fatal self-harm (regardless 
of intent) occurring in the study area and with individuals 
presenting to hospital11,12 over the 3–5 year follow-up 
period (between July 29, 2011, and May 12, 2016) of the 
trial. Data were collected from 11 small peripheral 
hospitals and two larger referral hospitals where sicker 
patients were cared for. Self-harm cases were identified 
by a team of research assistants who visited medical, 
surgical, paediatric, and intensive care wards in the 
two large hospitals daily and the 11 peripheral hospitals 
at least on alternate days. We had details of the hospital 
the patient initially presented to for 2945 (95·8%) of the 
3073 self-harm cases included in the study, 1993 (67·6%) 
Research in context
Evidence before this study
Hospital presenting self-harm is a high priority area for suicide 
prevention in high-income countries (HICs). A 2014 systematic 
review and meta-analysis suggested that 1·6% of individuals 
presenting to hospital with a self-harm episode go on to die by 
suicide in the next 12 months and 16% repeat self-harm. Only 
4% of all identified studies in the review were from low-income 
and middle-income countries (LMICs), where 75% of all suicide 
deaths occur (with only one study from south Asia), and the 
review found that risk of repeat self-harm and subsequent 
suicide was lower in Asia than in other regions. Because of a 
paucity of good quality self-harm surveillance systems in 
LMICs, this association has been difficult to investigate. 
We updated the 2014 systematic review by searching PubMed 
for relevant studies published between Jan 1, 2012, and 
Feb 28, 2019, with the search terms (suicid*) OR (self AND 
harm) OR (self poisoning) AND MesH terms for “cohort 
studies” OR “follow up studies” OR hospital re-admission OR 
“longitudinal studies”, with no language restrictions. A 2019 
large study investigating repeat self-poisoning in Sri Lanka 
reported a 12-month repeat rate of 5·7%, but focused on 
self-poisoning alone and did not investigate risk in relation to 
previous self-harm and the possible contribution of 
socioeconomic risk factors.
Added value of this study
By use of a self-harm surveillance register covering a population 
of more than 220 000 people in a south Asian LMIC (Sri Lanka), 
we estimated the risk of repeat self-harm and the risk of suicide 
to be considerably lower than in HICs. The risk of repeat 
self-harm and suicide was higher in men than in women but 
was not increased among those with a history of self-harm. 
To our knowledge, our study is the first sufficiently powered to 
study the risk of repeat self-harm and suicide after presentation 
with self-harm (all methods) in an LMIC. Only 8·5% of people 
who died by suicide had presented to hospital following 
self-harm in the previous 12 months. For the first time, to our 
knowledge, our study estimates the potential contribution of 
hospital-presenting self-harm and subsequent self-harm care 
to the overall burden of suicide in an LMIC.
Implications of all the available evidence
Although management and support of individuals who present 
to hospital with self-harm is a possible target for suicide 
prevention, the findings of this study suggest that it might be 
less important in a LMIC setting. Other strategies targeting 
more common risk factors (eg, access to lethal means, alcohol 
misuse, domestic violence, and poverty) might be more 
effective in reducing suicide mortality.
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of whom were initially admitted to one of the 
11 peripheral hospitals; the number of cases per 
peripheral hospital varied between 12 and 358. Deaths 
from self-harm that occurred before presentation at 
hospital were identified through systematic surveys of 
police stations and coroners’ records for the district. We 
use the term self-harm in this study to refer to any act of 
self-poisoning or self-injury, irrespective of motivation 
or suicidal intent. The study region was divided into ten 
areas (referred to as bands in the original),11 and random 
allocation and the pesticide storage box installation (the 
intervention evaluated in the trial from which data for 
this study were drawn) were rolled out in one area at a 
time, hence the variation in follow-up for each area. The 
surveillance system was developed in parallel to 
initiation of the trial in each area to ensure all self-harm 
episodes from study participants were identified after 
randomisation.
We included only episodes of self-harm that were 
linked back to an individual in the baseline survey and 
did not result in death at first episode in our analysis. 
Our cohort was restricted to individuals who were older 
than 10 years at the time of their first presentation to 
hospital with self-harm recorded on the surveillance 
system. As a quality assurance exercise, we revisited 
households 3 years after the start of the follow-up period 
and asked members to report on any self-harm attempts 
(fatal or non-fatal) that occurred in the household 
(appendix).
Ethics approval was received from the research ethics 
committees of the University of Peradeniya (Peradeniya, 
Sri Lanka) and Rajarata University of Sri Lanka 
(Mihintale, Sri Lanka). The chief village official was 
approached to seek consent for community enrolment; 
individual household verbal consent was then sought at 
the start of each household survey.
Procedures
We investigated the risk of fatal and non-fatal repeat 
self-harm in relation to the following: demographic 
characteristics (sex and age at first presentation, with 
four age bands [10–25 years; 26–40 years; 41–55 years; 
and ≥56 years]); medical history or clinical data (data on 
previous self-harm before the baseline survey obtained 
via questioning the household respondent; method of 
self-harm collected from hospital records or by 
interviewing the patient or accompanying person); and 
socioeconomic characteristics collected in the baseline 
survey. Household socioeconomic position was measured 
on the basis of a household asset score.13 This score is a 
composite three-level measure derived by combining 
data on household construction and motorised vehicle 
ownership as follows: low (no motorised vehicle and 
poor quality household construction); middle (either a 
motorised vehicle or moderate or high quality household 
construction); or high (motorised vehicle ownership and 
moderate or high quality household construction). These 
variables are well-established risk factors for repeat self-
harm and suicide in HICs and were well recorded in the 
trial forming the basis of this research,11,12 as they were 
either primary outcomes or considered potential effect 
modifiers.
Statistical analysis
We included all individuals who had complete data for all 
variables in the study in our primary analysis. We 
estimated the risks of all and fatal repeat self-harm at 
12 months and 24 months with the Kaplan-Meier 
method. We used Cox proportional hazard models, with 
robust standard errors to accommodate any clustering of 
outcome events within villages, to determine the 
associations between patient characteristics (eg, age, sex, 
socioeconomic position, previous self-harm, and method 
of self-harm) and the risk of fatal and non-fatal repeat 
self-harm. In the original trial,11 there were no clear 
differences in the risk of self-harm between the 
intervention and control groups (relative risk 0·93, 
95% CI 0·80–1·08; p=0·33), but we have taken the 
conservative approach of adjusting for the intervention 
arm in this analysis. The date of the index presentation 
was taken as time zero for the Cox proportional hazards 
models, with the time until first repeat episode of non-
fatal self-harm, until fatal self-harm, or until censoring 
(end of study follow-up) recorded for each participant. 
The proportional hazards assumption was tested for each 
model using the estat phtest routine in Stata, which uses 
Schoenfeld residuals.14
In an exploratory analysis, we fitted a Weibull survival 
model without covariates to the time to repeat events, 
with the shape parameter taken as an indication of 
See Online for appendix
Figure 1: Cohort identification
3073 self-harm episodes identified
2259 eligible index episodes
541 ineligible
        541 not linked back to an individual at baseline
2404 individuals identified with an 
            episode of fatal or non-fatal 
            self-harm
145 ineligible
 1 younger than 10 years at baseline
        144 fatal index episode
2532 linked to individual in full trial
           cohort of 223 861
128 repeat episodes excluded
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whether the risk of a further self-harm event was highest 
in the period immediately following the index event.
As an additional secondary analysis, we estimated the 
rate of hospital-presenting self-harm in the previous 
12 months in those who died by suicide, compared with 
the rate of hospital-presenting self-harm in the previous 
12 months in those who had not died by suicide at the 
end of the surveillance period (May 12, 2016). We used 
the full trial cohort dataset (223 861 participants), 
excluding those who were younger than 10 years at the 
time of the baseline survey, individuals with missing 
data, and individuals who had not been followed up for at 
least 12 months. We fitted age, sex, and intervention 
group adjusted logistic models with robust standard 
errors to account for the clustering of individuals within 
households.
We calculated the repetition risk excluding individuals 
who were reported as spending at least one month away 
from home in the year before the baseline survey. Given 
the size of the survey and scarce resources we did not 
collect detailed information regarding the reasons why 
people lived away from home. We added time away from 
home as a covariate and repeated the proportional hazard 
models to extend our sensitivity analysis.
All analyses were done with Stata version 15.1.
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. The corresponding author had full access to 
all the data in the study and had final responsibility for 
the decision to submit for publication.
Results
Between July 29, 2011, and May 12, 2016, we detected 
3073 episodes of self-harm (fatal and non-fatal) in our 
surveillance system, of which 2532 (82·3%) were linked 
back to an individual in the baseline survey (figure 1). 
These episodes occurred in 2404 individuals. We excluded 
one individual who was younger than 10 years at the time 
of index presentation. 144 of the 2403 index episodes 
resulted in death (figure 1), an overall case fatality of 6·0% 
(95% CI 5·1–7·0). 82 (6·4%) of 1272 pesticide poisoning 
episodes resulted in death, as did 14 (1·3%) of 1038 other 
poisoning episodes and 48 (51·6%) of 93 other methods of 
self-harm (hanging accounted for 35 [72·9%] of 48 other 
self-harm deaths). Therefore, we analysed 2259 eligible 
index episodes of self-harm. Self-poisoning was the most 
common method of non-fatal self-harm at first episode 
(2214 [98·0%] of 2259 patients), with more pesticide than 
non-pesticide self-poisoning episodes (table 1).
n First repeat 
self-harm, 
n (per 100 
person-years)
Time to repeat self-harm Fatal self-harm, 
n (per 100 
person-years)
Time to death by suicide
HR* (95% CI) p value HR* (95% CI) p value
Overall 2259 116 (2·7) ·· ·· 16 (0·4) ·· ··
Sex
Female 1136 38 (1·8) 1 (ref) 0·0021 1 (0) 1 (ref) 0·0093
Male 1123 78 (3·6) 2·0 (1·3–3·2) ·· 15 (0·7) 14·7 (1·9–111·9) ··
Age group, years
10–25 1238 72 (3·0) 1 (ref) 0·12† 4 (0·2) 1 (ref) 0·0027†
26–40 655 34 (2·7) 0·9 (0·6–1·5) ·· 7 (0·5) 3·3 (1·0–11·6) ··
41–55 264 4 (0·8) 0·3 (0·1–0·8) ·· 0 (0) ·· ··
≥56 102 6 (3·2) 1·1 (0·5–2·4) ·· 5 (2·7) 16·1 (4·3–59·9) ··
Household socioeconomic position‡
High 1218 64 (2·8) 1 (ref) 0·68§ 10 (0·4) 1 (ref) 0·18§
Medium 842 45 (2·7) 1·0 (0·7–1·4) ·· 3 (0·2) 0·4 (0·1–1·6) ··
Low 199 7 (1·9) 0·7 (0·3–1·6) ·· 3 (0·8) 1·9 (0·5–7·2) ··
Previous self-harm
No 2077 106 (2·7) 1 (ref) 0·93 15 (0·4) 1 (ref) 0·76
Yes 182 10 (2·8) 1·0 (0·5–2·1) ·· 1 (0·3) 0·7 (0·1–5·6) ··
Method of self-harm
Pesticide poisoning 1190 56 (2·4) 1 (ref) 0·00027§ 13 (0·5) 1 (ref) 0·047§
Other poisoning 1024 51 (2·7) 1·1 (0·7–1·7) ·· 3 (0·2) 0·3 (0·1–1·0) ··
Other method 45 9 (9·6) 3·9 (2·0–7·6) ·· 0 (0) ·· ··
P value refers to the risk of repetition (fatal or non-fatal) varied across the groups. HR=hazard ratio. *Models adjusted for the intervention arm of the trial.11 †Testing for no 
trend. ‡Household socioeconomic position measured by asset score. §Wald test comparing the model with and without the independent variable and using robust 
standard errors.
Table 1: HRs (95% CIs) based on robust standard errors for time to first self-harm repetition and time to death by suicide from index self-harm episode
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There were almost equal numbers of men and women 
in the study (table 1). 1238 (54·8%) of 2259 participants 
were aged 10–25 years at the time of index presentation. 
Previous self-harm (reported at the time of the baseline 
community survey) was recorded for 182 (8·1%) of 
2259 individuals.
Our primary analysis was applied to 2259 individuals 
with index hospital presentation for non-fatal self-harm, 
and this cohort was followed up for a median of 1·9 years 
(range 0·003–4·8; IQR 0·9–2·8). 127 (111 non-fatal and 
16 fatal) repeat self-harm episodes were reported in 
116 individuals (maximum number of repeats was four). 
The rate of first repetition of self-harm over 4319 person-
years of follow up was 2·7 per 100 person-years (95% CI 
2·2–3·2). 61 individuals self-harmed again within 
12 months of the index episode. By use of survival 
models, the estimated risk for repeat self-harm within 
12 months was 3·1% (95% CI 2·4–3·9; table 2). 
92 individuals self-harmed again within 24 months of the 
index episode, with a risk of repeat self-harm of 5·2% 
(95% CI 4·3–6·4; table 2). 13 deaths by suicide occurred 
within one year of the index episode of self-harm, and a 
further two deaths occurred within 2 years. We estimated 
the shape parameter for the Weibull survival model fitted 
to the time to repeat episodes to be 0·79 (95% CI 
0·67–0·93), showing that the risk of a repeat episode is 
highest in the period immediately following the index 
event, with the risk diminishing over time.
The risk of repeat self-harm was higher in men than in 
women (hazard ratio [HR] 2·0, 95% CI 1·3–3·2; p=0·0021) 
and in those who used other methods of self-harm for 
their first episode compared with those who used 
pesticides (4·0, 2·0–7·6; p=0·00027; figure 2; table 1). 
We found evidence against the proportional hazards 
assumption for the model investigating the association 
between previous history of self-harm and non-fatal 
repetition (p=0·020), but inspection of the Kaplan-Meier 
curves gave no suggestion of the estimated hazard ratio of 
1·0 being misleading (data not shown). Self-cutting 
(23 [51%] of 45 participants) and attempted hanging 
(15 [33%] of 45 participants) were the most common other 
methods used in a first episode of self-harm.
People generally used the same method in their repeat 
self-harm episode as in their index self-harm episode. 
56 individuals who repeated self-harm self-poisoned with 
pesticides at the index episode, and 35 (62·5%) of these 
used this same method in the second episode. 
51 individuals who repeated self-harm self-poisoned with 
a non-pesticide substance at the index episode, and 
32 (62·7%) of these used the same method at the 
second episode. Nine individuals used a method other 
than self-poisoning in the index episode, and four (44·4%) 
of these used a non-self-poisoning method in the second 
episode.
There were 16 deaths by suicide after index hospital 
presentation for non-fatal self-harm. The risk of fatal 
n Self-harm repetition risk Suicide death risk
12 months 24 months 12 months 24 months
Overall 2259 3·1% (2·4–3·9), 61 5·2% (4·3–6·4), 92 0·6% (0·4–1·1), 13 0·8% (0·5–1·3), 15
Sex
Female 1136 2·1% (1·3–3·2), 20 3·1% (2·2–4·5), 28 0·1% (0·0–0·8), 1 0·1% (0·0–0·8), 1
Male 1123 4·1% (3·0–5·5), 41 7·3% (5·7–9·2), 64 1·1% (0·7–2·1), 12 1·5% (0·9–2·5), 14
Age group, years
10–25 1238 3·3% (2·4–4·5), 36 5·2% (4·0–6·8), 52 0·3% (0·1–0·9), 4 0·3% (0·1–0·9), 4
26–40 655 3·5% (2·3–5·4), 20 6·2% (4·4–8·8), 31 0·9% (0·4–2·2), 5 1·1% (0·5–2·5), 6
41–55 264 0·4% (0·1–2·7), 1 1·7% (0·5–5·3), 3 ·· ··
≥56 102 4·2% (1·6–10·8), 4 7·1% (2·9–16·9), 6 4·2% (1·6–10·8), 4 6·1% (2·5–14·6), 5
Household socioeconomic position*
High 1218 3·1% (2·3–4·4), 34 5·6% (4·3–7·4), 53 0·7% (0·4–1·5), 8 0·9% (0·4–1·7), 9
Medium 842 3·1% (2·1–4·7), 23 4·8% (3·4–6·7), 32 0·4% (0·1–1·4), 3 0·4% (0·1–1·4), 3
Low 199 2·4% (0·9–6·2), 4 4·7% (2·2–9·6), 7 1·0% (0·3–4·0), 2 1·7% (0·6–5·4), 3
Previous self-harm
No 2077 3·2% (2·5–4·1), 59 5·4% (4·4–6·6), 87 0·7% (0·4–1·2), 13 0·8% (0·5–1·4), 14
Yes 182 1·3% (0·3–5·1), 2 3·6% (1·5–8·4), 5 ·· 0·7% (0·1–5·0), 1
Method of self-harm
Pesticide poisoning 1190 2·8% (1·9–3·9), 30 4·8% (3·6–6·4), 45 0·9% (0·5–1·7), 10 1·2% (0·7–2·1), 12
Other poisoning 1024 3·1% (2·1–4·5), 27 5·1% (3·8–7·0), 40 0·4% (0·1–1·2), 3 0·4% (0·1–1·2), 3
Other method 45 9·6% (3·7–23·6), 4 17·8% (8·9–33·9), 7 ·· ··
Data are risk (95% CI), n, unless otherwise indicated. *Household socioeconomic position measured by asset score.
Table 2: Kaplan-Meier estimates of 12-month and 24-month risk of repeat self-harm and death by suicide after index hospital presentation with 
self-harm
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self-harm after index presentation with self-harm was 
0·6% (95% CI 0·4–1·1) within 12 months and 0·8% 
(0·5–1·3) within 24 months (table 2). The risk of suicide 
was most increased in men (HR 14·7, 95% CI 1·9–111·9; 
p=0·0093) and in those aged 56 years and older (16·1, 
4·3–59·9; p=0·0027) at the time of their index episode 
(table 1).
We did a sensitivity analysis to explore whether the risk 
of repeat self-harm and suicide was similar in 1553 (69%) 
of 2259 study cohort members who reported spending 
less than 1 month away from their home, compared with 
the findings for the entire study cohort. Reasons for 
spending time away from the home included working on 
agricultural land, living at another address, or working at 
some distance from the home (eg, garment factory 
worker). The risk of non-fatal repeat self-harm and 
suicide (in those residing in their homes at least 
11 months of the previous year) at 12 months (self-harm 
repetition 3·1%; suicide death 0·7%) and 24 months 
(self-harm repetition 5·3%; suicide death 0·9%) was 
consistent with our main analysis findings. Results from 
the proportional hazard models when the proportion of 
time away from home was included as a covariate did not 
alter our conclusions (data not shown).
160 deaths by suicide were recorded on the self-harm 
surveillance system over the study period, only 16 (10·0%) 
of which occurred after an episode of self-harm recorded 
on the surveillance register. 118 (73·8%) of 160 deaths by 
suicide occurred after the first 12 months of surveillance 
follow-up. In a secondary analysis, we compared these 
individuals who died by suicide with individuals older 
than 10 years at the time of the baseline survey who had 
not died by suicide at the end of the surveillance period 
and had complete data for the variables of interest. In 
the 12 months before death by suicide, 10 (8·5%) of 
118 individuals who died by suicide (95% CI 4·1–15·0) 
presented to hospital with self-harm, compared with 
598 (0·3%) of 183 277 individuals (3·3 per 1000 individuals; 
95% CI 3·0–3·5) who presented to hospital with self-
harm but did not die by suicide in the 12 months before 
the end of surveillance. People who died by suicide were 
36·7 times (95% CI 18·7–71·7) more likely to have 
presented to hospital with self-harm in the 12 months 
before their death compared with those who did not die 
by suicide (adjusted for age, sex, and intervention arm; 
appendix).
To check for episodes of self-harm that did not result in 
presentation to hospital and assess levels of emigration 
from the study area, the household survey team revisited 
13 999 (26·2%) of 53 382 households in the study area 
between Jan 31, 2015, and July 31, 2016, and found only 
269 self-harm attempts were reported to have occurred 
between the time of the baseline survey and resurvey by 
household members, of which 247 (91·8%) were reported 
to have presented to hospital. Emigration from the study 
area during the trial follow-up period was modest (6520 
[11%] of 59 025 residents of revisited households).
Discussion
To our knowledge, this is the largest prospective study 
from a LMIC in south Asia to estimate the risk of repeat 
self-harm by any method. We observed a 3·1% risk 
(95% CI 2·4–3·9) of repeat self-harm and a 0·6% risk 
(0·4–1·1) of death by suicide at 12 months after index 
hospital presentation with self-harm. We observed a 
2 times higher risk of non-fatal and fatal repeat self-harm 
in men compared with women and a 16 times higher risk 
of fatal self-harm in people aged 56 years or older versus 
those aged 10–25 years at index case hospital presentation. 
We found evidence that the risk of self-harm repetition 
was higher in those who used methods other than self-
poisoning (HR 3·9) at their index presentation, compared 
with those who self-poisoned with pesticides. We found 
no evidence that previous self-harm increased the risk of 
repeat self-harm or suicide. We found that 8·5% of 
individuals who died by suicide in this study had 
presented to hospital with self-harm in the 12 months 
before their death. People who died by suicide were 
36·7 times more likely to have presented to hospital with 
self-harm 12 months before their death compared with 
those who did not die by suicide.
The risk of repeat non-fatal self-harm in this study was 
considerably lower than that reported in a 2014 systematic 
review and meta-analysis of repetition of hospital 
presenting self-harm,2 with no overlap in the 95% CIs for 
the corresponding estimates from the two studies 
(table 3).2 This systematic review2 identified only seven 
papers (4% of all identified research) from LMICs, with 
only one study from south Asia.7 We observed a higher 
risk of repeat self-harm in men compared with women 
(HR 2·0, 95% CI 1·3–3·2). The systematic review2 found 
no difference between men and women, but a more 
recent large follow-up study10 of people presenting to 
hospital after self-poisoning in Sri Lanka also reported an 
Figure 2: Kaplan-Meier graph of time to the first non-fatal repeat episode of self-harm by sex
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increased risk of repeat self-poisoning in men compared 
with women (odds ratio 1·3, 95% CI 1·0–1·6). The risk of 
death by suicide 12 months after the index episode was 
also substantially lower in our study compared with the 
systematic review estimate2 (table 3), but was more 
similar to the 2-year suicide risk of 0·7% (95% CI 
0·4–0·9) reported by Pushpakumara and colleagues.10 
Our findings of an elevated risk of suicide in men 
compared with women after index self-harm presentation 
are consistent with the systematic review.2
A possible reason for the lower observed risk of repeat 
self-harm in Asia is that pesticide self-poisoning has a 
high case fatality rate, thereby removing those at a higher 
risk of repetition.6,15,16 Over the past three decades there 
have been a series of pesticide bans, most recently in 
2008–11, which have contributed to a reduction in the 
number of pesticide-related deaths by suicide in 
Sri Lanka.17–19 These bans have resulted in marked 
reductions in the case fatality associated with pesticide 
self-poisoning. In this study, we observed a case fatality 
rate of 6%, substantially lower than that previously 
observed in national and secondary hospital data 
(11–12%),20,21 and supporting the positive effect of 
pesticide regulations on suicide mortality trends. Even if 
the 144 (6·4%) individuals who died on their index 
presentation survived and went on to repeat self-harm 
within 12 months, the 12-month repetition rate would be 
only 8·5%, which is substantially lower than that in 
HICs. Other possible reasons for the low prevalence of 
repeat self-harm in Asia are the lower prevalence of 
mental disorders among those who self-harm compared 
to levels seen in HICs22 and longer inpatient stays helping 
individuals get through the period of greatest risk of 
repeat self-harm. Our estimates of a lower rate of self-
harm repetition are consistent with previous estimates of 
repetition from south Asia,6,8–10 but lower than the 
12-month repetition rate from a prospective study from 
India (14%, 95% CI 10–19).7 Possible explanations for 
these differences might be differing methodology in the 
Indian study, including collection of data on self-reported 
self-harm, or differences in the socioeconomic and 
psychological health of our study population.
Previous studies have shown that the risk of repeat self-
harm is higher in individuals who present with self-
cutting compared with self-poisoning.23,24 This finding is 
consistent with our study results, as we observed a greatly 
elevated risk of repeat self-harm after index presentations 
with other methods of self-harm (which included a large 
proportion of self-cutting).
Compared with previous research, we observed a lower 
risk of self-harm in the year before death by suicide 
(8·5% vs 15%3). However, when compared with those 
who did not die by suicide in this study, a previous self-
harm attempt (in the last 12 months) was associated with 
an increased risk of suicide. Although those who present 
to hospital with self-harm are an attractive target for 
suicide prevention (assuming a causal relationship) only 
8·5% (population attributable fraction) of individuals 
who died by suicide had presented to hospital with self-
harm in our study.
Our study has some limitations that should be 
considered when interpreting the findings. First, the 
study focused on non-fatal self-harm that resulted in 
presentation to hospital. Some self-harm might not result 
in hospital presentation, and this would particularly be the 
case for non-poisoning episodes like self-cutting; however, 
our follow up household survey findings suggested that 
our estimates of repeat self-harm are unlikely to be 
greatly underestimated. Second, the surveillance register 
collected restricted clinical and diagnostic data, which 
limits our ability to explore these as risk factors for 
repetition. Third, we do not know whether individuals 
presented to hospital for repeat self-harm outside the 
study area. However, the household resurvey suggested 
that emigration from the study area during the trial follow-
up period was modest (11%) and every attempt was made 
to collect cases from hospitals that were close to the study 
area, minimising missing cases.11 Fourth, because the 
study was done in a rural area where 80% of households 
were involved in farming and 98% of self-harm episodes 
involved self-poisoning, most often by pesticides, the 
findings might be less applicable to urban LMIC settings, 
where the socioeconomic circumstances and methods 
used for self-harm are different, and to rural LMIC 
settings that use different farming methods. Finally, there 
were only 16 suicide deaths in those who presented to 
hospital with an index self-harm episode. Therefore, the 
study is probably underpowered to detect anything but a 
large difference in risk for the potential risk variables that 
we investigated for suicide.
We estimate that 5·2% of patients who have self-
harmed will self-harm again within 2 years of an index 
hospital presentation in Sri Lanka. An estimated 8 (0·8%) 
of every 1000 individuals will go on to die by suicide in 
the same time period. Although the rate of previous self-
harm (at 12 months) in those who died by suicide in this 
study was lower than in HICs, hospital presenting self-
harm remains a substantial risk factor for suicide; 
nevertheless, the population attributable risk for this 
exposure was only 8·5%. Based on the findings of this 
study, focusing suicide prevention efforts on those who 
self-harm might be somewhat less important in LMICs 
12-month risk 
(95% CI)
24-month risk 
(95% CI)
Non-fatal self-harm
This study 3·1% (2·4–3·9) 5·2% (4·3–6·4)
Carroll et al, 20142 16·3% (15·1–17·7) 16·8% (14·7–19·2)
Fatal self-harm
This study 0·6% (0·4–1·1) 0·8% (0·5–1·3)
Carroll et al, 20142 1·6% (1·2–2·4) 2·1% (1·6–2·8)
Table 3: Estimated risk of repeat self-harm (non-fatal and fatal) in the 
present study compared with the Carroll et al meta-analysis2
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compared with HICs given the low risk of repeat self-
harm and death by suicide. Strategies that focus on other 
risk factors for suicide (eg, access to lethal means, 
domestic violence, harmful alcohol use), or on improved 
mental health support or welfare support, might be more 
effective in reducing suicide deaths in LMICs in south 
Asia. Further research investigating the reasons under-
lying the low rate of repeat self-harm is needed, as a 
better understanding of this phenomenon might con-
tribute to prevention strategies in nations with a higher 
incidence of repeat self-harm and subsequent death by 
suicide.
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